M. L. Mashford

1.1k total citations
39 papers, 867 citations indexed

About

M. L. Mashford is a scholar working on Genetics, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M. L. Mashford has authored 39 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Pharmacology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M. L. Mashford's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Pharmaceutical Practices and Patient Outcomes (3 papers) and Poisoning and overdose treatments (3 papers). M. L. Mashford is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Pharmaceutical Practices and Patient Outcomes (3 papers) and Poisoning and overdose treatments (3 papers). M. L. Mashford collaborates with scholars based in Australia, United States and South Korea. M. L. Mashford's co-authors include Michael L. Roberts, Sune Rosell, Göran Nilsson, Åke Rökaeus, John D. Horowitz, Samuel F. Berkovic, Graham J. Schapel, Paul Desmond, W. C. Yuen and Frank Vajda and has published in prestigious journals such as The Lancet, Antimicrobial Agents and Chemotherapy and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

M. L. Mashford

38 papers receiving 824 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. L. Mashford Australia 16 173 169 163 152 148 39 867
Edward T. Zawada United States 18 197 1.1× 76 0.4× 56 0.3× 159 1.0× 66 0.4× 88 1.1k
Barry R. Walker United States 17 94 0.5× 88 0.5× 37 0.2× 59 0.4× 58 0.4× 42 723
J G Gerber United States 20 237 1.4× 91 0.5× 66 0.4× 123 0.8× 25 0.2× 47 1.2k
K. Siersbæk‐Nielsen Denmark 17 121 0.7× 310 1.8× 28 0.2× 475 3.1× 148 1.0× 78 1.4k
Akihiro Tanaka Japan 19 106 0.6× 82 0.5× 63 0.4× 44 0.3× 48 0.3× 78 1.1k
Hannu Allonen Finland 21 137 0.8× 293 1.7× 52 0.3× 89 0.6× 157 1.1× 64 1.5k
A. E. Doyle Australia 19 494 2.9× 67 0.4× 65 0.4× 318 2.1× 31 0.2× 76 1.3k
Bruno Michel France 14 165 1.0× 95 0.6× 53 0.3× 80 0.5× 55 0.4× 95 828
A. C. Corcoran United States 21 359 2.1× 66 0.4× 40 0.2× 243 1.6× 35 0.2× 106 1.7k
C Aguirre Spain 18 107 0.6× 111 0.7× 34 0.2× 70 0.5× 140 0.9× 55 846

Countries citing papers authored by M. L. Mashford

Since Specialization
Citations

This map shows the geographic impact of M. L. Mashford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. L. Mashford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. L. Mashford more than expected).

Fields of papers citing papers by M. L. Mashford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. L. Mashford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. L. Mashford. The network helps show where M. L. Mashford may publish in the future.

Co-authorship network of co-authors of M. L. Mashford

This figure shows the co-authorship network connecting the top 25 collaborators of M. L. Mashford. A scholar is included among the top collaborators of M. L. Mashford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. L. Mashford. M. L. Mashford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Debinski, Henry, Peter I. Mackenzie, M. L. Mashford, et al.. (1996). UDP glucuronosyltransferase in the cirrhotic rat liver. Journal of Gastroenterology and Hepatology. 11(4). 373–379. 16 indexed citations
2.
Desmond, Paul, Fiona E. Smyth, & M. L. Mashford. (1994). Release of latent glucuronosyltransferase activity contributes to the sparing of glucuronidation in experimental liver injuries. Journal of Gastroenterology and Hepatology. 9(4). 350–354. 11 indexed citations
3.
Schapel, Graham J., Roy G. Beran, Frank Vajda, et al.. (1993). Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures.. Journal of Neurology Neurosurgery & Psychiatry. 56(5). 448–453. 135 indexed citations
4.
Allen, Terri J., George Jerums, M. De Luise, et al.. (1991). Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. 302(6770). 210–216. 189 indexed citations
5.
Wallace, Sophie, et al.. (1990). Covert self poisoning with brodifacoum, a ‘superwarfarin’. Australian and New Zealand Journal of Medicine. 20(5). 713–715. 8 indexed citations
6.
Mashford, M. L., et al.. (1989). Factors influencing prescribing. The Medical Journal of Australia. 150(1). 52–52. 22 indexed citations
7.
Harvey, Ken, et al.. (1988). Changing antibiotic prescribing by educational marketing. The Medical Journal of Australia. 149(11-12). 595–599. 50 indexed citations
8.
Mashford, M. L., et al.. (1981). Cardiac Arrest after Intravenous Injection of Cimetidine. Survey of Anesthesiology. 25(5). 288–288.
9.
Bury, Ross W. & M. L. Mashford. (1981). USE OF A DRUG‐SCREENING SERVICE IN AN INNER‐CITY TEACHING HOSPITAL. The Medical Journal of Australia. 1(3). 132–133. 13 indexed citations
10.
Horowitz, John D. & M. L. Mashford. (1980). Venoconstrictor Activity of Some Precursor Fractions of Stable Plasma Protein Solution. Vox Sanguinis. 38(5). 266–271. 2 indexed citations
11.
Bury, Ross W., et al.. (1979). Assay of flucytosine (5-fluorocytosine) in human plasma by high-pressure liquid chromatography. Antimicrobial Agents and Chemotherapy. 16(5). 529–532. 15 indexed citations
12.
Horowitz, John D. & M. L. Mashford. (1979). Long‐Term Safety of Perhexiline Maleate. The Medical Journal of Australia. 1(6). 232–232. 1 indexed citations
13.
Horowitz, John D. & M. L. Mashford. (1976). A vasodepressor peptide in cohn fraction III-0 of human plasma proteins. Inflammation Research. 6(4). 429–429. 1 indexed citations
14.
Mashford, M. L. & Michael L. Roberts. (1972). Determination of blood kinin levels by radioimmunoassay. Biochemical Pharmacology. 21(20). 2727–2735. 51 indexed citations
15.
Mashford, M. L. & Michael L. Roberts. (1971). CAUSE OF FLUSHING IN CARCINOID SYNDROME. The Lancet. 298(7728). 817–817. 1 indexed citations
16.
Gannon, B. J., Takashi Iwayama, Geoffrey Burnstock, John F. Gerkens, & M. L. Mashford. (1971). PROLONGED EFFECTS OF CHRONIC GUANETHIDINE TREATMENT ON THE SYMPATHETIC INNERVATION OF THE GENITALIA OF MALE RATS. The Medical Journal of Australia. 2(4). 207–208. 37 indexed citations
17.
Mashford, M. L. & John D. Horowitz. (1968). A Perfused Vein Preparation Sensitive to Plasma Kinins.. Immunology and Cell Biology. 46(4). 1 indexed citations
18.
Mashford, M. L. & R. Zacest. (1967). EFFECT OF ADRENALINE ON BLOOD KININ LEVELS IN CARCINOID SYNDROME AND IN NORMAL SUBJECTS. Australasian Annals of Medicine. 16(4). 326–329. 3 indexed citations
19.
Mashford, M. L. & R. Zacest. (1967). PHYSIOLOGICAL CHANGES IN BLOOD BRADYKININ LEVELS IN MAN. Immunology and Cell Biology. 45(6). 661–673. 9 indexed citations
20.
Brown, Malcolm J., John D. Horowitz, & M. L. Mashford. (1962). A DOUBLE‐BLIND TRIAL OF PERHEXILINE MALEATE IN THE PROPHYLAXIS OF ANGINA PECTORIS. The Medical Journal of Australia. 1(9). 260–263. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward T. Zawada Breakdown of academic impact, for papers by Barry R. Walker Breakdown of academic impact, for papers by J G Gerber Breakdown of academic impact, for papers by K. Siersbæk‐Nielsen Breakdown of academic impact, for papers by Akihiro Tanaka Breakdown of academic impact, for papers by Hannu Allonen Breakdown of academic impact, for papers by A. E. Doyle Breakdown of academic impact, for papers by Bruno Michel Breakdown of academic impact, for papers by A. C. Corcoran Breakdown of academic impact, for papers by C Aguirre
Rankless by CCL
2026